Cantor Fitzgerald initiated coverage of BridgeBio Oncology (BBOT) with an Overweight rating.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.